{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:52:18Z","timestamp":1756896738216},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metastatic tumors to the breast reportedly account for 0.5% to 2.0% of all malignant breast diseases. Such metastatic tumors must be differentiated from primary breast cancer. Additionally, few reports have described metastases of gynecological cancers to the breast. We herein report two cases of metastasis of pelvic high-grade serous adenocarcinoma to the breast.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The first patient was a 57-year-old woman with a transverse colon obstruction. Colostomy was performed, but the cause of the obstruction was unknown. We found scattered white nodules disseminated throughout the abdominal cavity and intestinal surface. Follow-up contrast-enhanced computed tomography (CT) showed an enhanced nodule outside the right mammary gland. Core needle biopsy (CNB) of the right breast mass was conducted, and immunohistochemical staining of the mass suggested a high-grade serous carcinoma of female genital tract origin. We diagnosed the patient\u2019s condition as breast and lymph node metastasis of a high-grade serous carcinoma of the female genital tract. After chemotherapy for stage IVB peritoneal cancer, tumor reduction surgery was performed. The second patient was a 71-year-old woman with a medical history of low anterior resection for rectal cancer at age 49, partial right thyroidectomy for follicular thyroid cancer at age 53, and left lower lung metastasis at age 57. Periodic follow-up CT showed peritoneal dissemination, cancerous peritonitis, and pericardial effusion, and the patient was considered to have a cancer of unknown primary origin. Contrast-enhanced CT showed an enhanced nodule in the left mammary gland with many enhanced nodules and peritoneal thickening in the abdominal cavity. CNB of the left breast mass was conducted, and immunohistochemical staining of the mass suggested a high-grade serous carcinoma of female genital tract origin. After chemotherapy for stage IVB peritoneal cancer, tumor reduction surgery was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We experienced two rare cases of intramammary metastasis of high-grade serous carcinoma of female genital tract origin. CNB was useful for confirming the histological diagnosis of these cancers that had originated from other organs. A correct diagnosis of such breast tumors is important to ensure quick and appropriate treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-020-01090-7","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T17:21:27Z","timestamp":1607534487000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breast metastasis from pelvic high-grade serous adenocarcinoma: a report of two cases"],"prefix":"10.1186","volume":"6","author":[{"given":"Yurina","family":"Harada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Zaguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Ohgami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"1090_CR1","first-page":"49","volume":"179","author":"B Chaingnaud","year":"1994","unstructured":"Chaingnaud B, Hall TJ, Powers C, Subramony C, Scott-Conner CE. Diagnosis and natural history of extramammary tumors metastatic to the breast. J Am Coll Surg. 1994;179:49\u201353.","journal-title":"J Am Coll Surg"},{"key":"1090_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3919\/jjsa.59.221","volume":"59","author":"A Tachibana","year":"1998","unstructured":"Tachibana A, Fukuma E, Ui Y, Yamakawa T, Mizuguchi K. A case of ovarian cancer with breast metastasis. J Jpn Surg Assoc. 1998;59:221\u20135.","journal-title":"J Jpn Surg Assoc"},{"key":"1090_CR3","first-page":"859","volume":"62","author":"S Maruyama","year":"2007","unstructured":"Maruyama S, Masuda H, Fujii T, Kunisue H, Kanaya Y, Yokoyama N, et al. A case of breast metastasis from ovarian cancer. J Jpn Surg Assoc. 2007;62:859\u201362.","journal-title":"J Jpn Surg Assoc"},{"key":"1090_CR4","first-page":"311","volume":"58","author":"T Yui","year":"2009","unstructured":"Yui T, Ishitani K, Konno J, Fukagawa F, Ueda E, Nomura H, et al. A case of ovarian serous adenocarcinoma with breast metastasis. Tokyo J Obstet Gynecol. 2009;58:311\u20135.","journal-title":"Tokyo J Obstet Gynecol"},{"key":"1090_CR5","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3919\/jjsa.73.2083","volume":"73","author":"S Suehiro","year":"2012","unstructured":"Suehiro S, Yamashita S, Kamei M, Kawahara K, Daa T, Kashima K. A case of breast metastasis from ovarian cancer diagnosed as primary breast cancer preoperatively. J Jpn Surg Assoc. 2012;73:2083\u20136.","journal-title":"J Jpn Surg Assoc"},{"key":"1090_CR6","first-page":"683","volume":"34","author":"W Takao","year":"2016","unstructured":"Takao W, Sakurai M, Shikama A, Tasaka N, Nakao S, Ochi H, et al. A case of ovarian cancer serous carcinoma stage 4B with breast metastasis from the first treatment. Jpn J Gynecol Oncol. 2016;34:683\u20137.","journal-title":"Jpn J Gynecol Oncol"},{"key":"1090_CR7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3919\/jjsa.78.1999","volume":"78","author":"A Ikari","year":"2017","unstructured":"Ikari A, Tanaka S, Nitta T, Tanishima H, Horiuchi T, Hoshida Y. A case of breast metastasis from ovarian cancer with calcification. J Jpn Surg Assoc. 2017;78:1999\u20132004.","journal-title":"J Jpn Surg Assoc"},{"key":"1090_CR8","first-page":"337","volume":"33","author":"F Kimura","year":"2018","unstructured":"Kimura F, Oda G, Hanaoka M, Nakagawa T, Bee Y, Kubota K, et al. Ovarian cancer breast metastasis, A case report of intramammary lymph node metastasis from ovarian cancer experienced in our hospital and review of the literature. Jpn J Breast Cancer. 2018;33:337\u201341.","journal-title":"Jpn J Breast Cancer"},{"key":"1090_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/gyno.1993.1223","volume":"50","author":"JD Bloss","year":"1993","unstructured":"Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, et al. Extraovarian peritoneal serous papillary carcinoma: a case\u2013control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347\u201351.","journal-title":"Gynecol Oncol"},{"issue":"66","key":"1090_CR10","first-page":"1024","volume":"2014","author":"Report by the Japan Obstetrics and Gynecology Society Gynecology Oncology Committee","year":"2012","unstructured":"Report by the Japan Obstetrics and Gynecology Society Gynecology Oncology Committee. annual report of patients. Acta Obstet Gynaecol Jpn. 2012;2014(66):1024\u201338.","journal-title":"Acta Obstet Gynaecol Jpn"},{"key":"1090_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/gyno.1998.5267","volume":"72","author":"I Alvarado-Cabrero","year":"1999","unstructured":"Alvarado-Cabrero I, Young RH, Vamvakas EC, Scully RE. Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol. 1999;72:367\u201379.","journal-title":"Gynecol Oncol"},{"key":"1090_CR12","first-page":"156","volume-title":"Japan Society of Gynecologic Oncology Guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer","author":"S Komiyama","year":"2015","unstructured":"Komiyama S, Katabuchi H, Mikami M, Nagase S, Okamoto A, Ito K, et al. Japan Society of Gynecologic Oncology Guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer. Tokyo: KANEHARA & CO., LTD.; 2015. p. 156\u20138."},{"key":"1090_CR13","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in oncology. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer, version 1. 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf. Accessed 6 Apr 2020."},{"key":"1090_CR14","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","volume":"34","author":"AA Wright","year":"2016","unstructured":"Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, et al. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: society of gynecologic oncology and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34:3460\u201373.","journal-title":"J Clin Oncol"},{"key":"1090_CR15","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1200\/JCO.2007.11.5345","volume":"25","author":"RA Burger","year":"2007","unstructured":"Burger RA, Sill MW, Monk BJ, Greer BE, Sorosky JI. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:5165\u201371.","journal-title":"J Clin Oncol"},{"key":"1090_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ygyno.2009.03.020","volume":"114","author":"GD Aletti","year":"2009","unstructured":"Aletti GD, Powless C, Bakkum-Gamez J, Wilson TO, Podratz KC, Cliby WA. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy. Gynecol Oncol. 2009;114:32\u20136.","journal-title":"Gynecol Oncol"},{"key":"1090_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ygyno.2005.09.020","volume":"100","author":"J Menczer","year":"2006","unstructured":"Menczer J, Chetrit A, Barda G, Lubin F, Fishman A, Dgani R, et al. Primary peritoneal carcinoma\u2014uterine involvement and hysterectomy. Gynecol Oncol. 2006;100:565\u20139.","journal-title":"Gynecol Oncol"},{"key":"1090_CR18","first-page":"3584","volume":"44","author":"D Tarin","year":"1984","unstructured":"Tarin D, Prie JE, Kettlewell MG, Souter RG, Vass AC, Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 1984;44:3584\u201392.","journal-title":"Cancer Res"},{"key":"1090_CR19","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/1097-0142(197206)29:6<1691::AID-CNCR2820290637>3.0.CO;2-4","volume":"29","author":"SI Hajdu","year":"1972","unstructured":"Hajdu SI, Urban JA. Cancers metastatic to the breast. Cancer. 1972;29:1691\u20136.","journal-title":"Cancer"},{"key":"1090_CR20","first-page":"33","volume":"33","author":"H Nakamura","year":"2012","unstructured":"Nakamura H, Takehara K, Kusumoto S, Sasaki A, Yamazaki T, Samura O, et al. A case of cervical serous adenocarcinoma. Hiroshima Bull Jap Soc Clin Cytol. 2012;33:33\u20137.","journal-title":"Hiroshima Bull Jap Soc Clin Cytol"},{"key":"1090_CR21","first-page":"3144","volume":"7","author":"M Sekine","year":"2001","unstructured":"Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, et al. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res. 2001;7:3144\u201350.","journal-title":"Clin Cancer Res"},{"key":"1090_CR22","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology Genetic\/Familial High-Risk Assessment. Breast, ovarian, and pancreatic, version 1. 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf. Accessed 16 Aug 2020."},{"issue":"suppl 6","key":"1090_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/annonc\/mdr373","volume":"22","author":"J Balmana","year":"2011","unstructured":"Balmana J, Diez O, Rubio IT, Cardoso F. BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(suppl 6):31\u20134.","journal-title":"Ann Oncol"},{"key":"1090_CR24","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","volume":"375","author":"MR Mirza","year":"2016","unstructured":"Mirza MR, Monk BJ, Herrstedt J, Oza AM, Mahner S, Redondo A, et al. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N Engl J Med. 2016;375:2154\u201364.","journal-title":"N Engl J Med"},{"key":"1090_CR25","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(17)32440-6","volume":"390","author":"RL Coleman","year":"2017","unstructured":"Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390:1949\u201361.","journal-title":"Lancet"},{"key":"1090_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S1470-2045(13)70363-2","volume":"14","author":"N Katsumata","year":"2013","unstructured":"Katsumata N, Yasuda M, Isonishi S, Takahashi F, Michimae H, Kimura E, Japanese Gynecologic Oncology Group, et al. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial. Lancet Oncol. 2013;14:1020\u20136.","journal-title":"Lancet Oncol"},{"key":"1090_CR27","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(19)32259-7","volume":"394","author":"AR Clamp","year":"2019","unstructured":"Clamp AR, James EC, McNeish IA, Dean A, Kim JW, O\u2019Donnell DM, et al. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phrase 3 randomised controlled trial. Lancet. 2019;394:2084\u201395.","journal-title":"Lancet"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-01090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-020-01090-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-01090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T17:29:49Z","timestamp":1607534989000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-020-01090-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1090"],"URL":"https:\/\/doi.org\/10.1186\/s40792-020-01090-7","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"17 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was approved by the research ethics committee of Kyushu University Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of this case report was obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MK has received honorariums as a speaker or consultant\/advisory role from Chugai Pharmaceutical Co. (Tokyo, Japan). The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}